ZENOCUTUZUMAB

UNII:	AE72RB1W1X
Formula:
Preferred Substance Name:	ZENOCUTUZUMAB

1969309-56-5
BIZENGRI
IMMUNOGLOBULIN G1, BISPECIFIC, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTORS, HER2 AND HER3) (HUMANIZED CLONE MCLA-128 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE MCLA-128 LIGHT CHAIN, DIMER
MCLA128
MCLA-128
MCLA-128 (IGG1 BISPECIFIC ANTIBODY WITH ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) ACTIVITY TARGETING HER2 AND HER3 RECEPTORS.)
ZENOCUTUZUMAB [INN]
ZENOCUTUZUMAB [USAN]
ZENOCUTUZUMAB [WHO-DD]
ZENOCUTUZUMAB ZBCO [WHO-DD]
ZENOCUTUZUMAB-ZBCO

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZENOCUTUZUMAB

Synonyms and Mappings

Resources